Search - tctmd.com

Displaying 341 - 360 of 417

Sort: Relevancy | Date

Presentation TCT 2015

The Clinical Impact of Stroke With 2 Preventative Strategies: LAA Closure vs Chronic Oral Anticoagulation

Presenter: Reda Ibrahim, Matthew J. Price, Vivek Y. Reddy

October 11, 2015

Presentation TCT 2015

KEYNOTE LECTURE: Transcatheter Valve Replacement for Bioprosthetic Valve Failure Gold Standard vs Selective Application (The VIVID Registry)

Presenter: Martin B. Leon, Neil E. Moat, Danny Dvir

October 11, 2015

Presentation TCT 2015

Are Ablation and LAA Closure Complementary Approaches in the Patient With Paroxysmal AF With Moderate Stroke Risk?

Presenter: David R. Holmes Jr., Vivek Y. Reddy, DJ Lakkireddy

October 11, 2015

Presentation TCT 2015

Guidelines, Recommendations, and Reimbursement for LAA Closure: A Global Survey

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Saibal Kar

October 11, 2015

Presentation TCT 2015

Guidelines, Recommendations, and Reimbursement for LAA Closure: A Global Survey

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Saibal Kar

October 11, 2015

Presentation TCT 2015

Shades of Gray? Defining the Range of Patients Contraindicated for Anticoagulation

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Piera Capranzano

October 11, 2015

Presentation TCT 2015

Surgical LAA Closure: Patient Selection and Supporting Data

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Michael Argenziano

October 11, 2015

Presentation TCT 2015

Outcome of Patients With Atrial Fibrillation and Stent Implantation: Results of the Prospective LASER Registry

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Uwe Zeymer

October 11, 2015

Presentation TCT 2015

What Are the Management Options for the Patient With AF and DES?

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Pascal Vranckx

October 11, 2015

Presentation TCT 2015

Which NOAC for Which Patient?

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Christopher B. Granger

October 11, 2015

Presentation TCT 2015

Weighing the Risk of Stroke in Atrial Fibrillation vs the Risk of Bleeding on Anticoagulation

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Neal S. Kleiman

October 11, 2015

Presentation TVT 2015

Updates on Mitral Valve-in-Valve/Ring Outcomes From the VIVID Registry

Presenter: Vinayak Bapat, Danny Dvir

June 05, 2015

Presentation TVT 2015

Important Lessons From the Global Valve-in-Valve (VIVID) Registry

Presenter: Vinayak Bapat, Danny Dvir

June 05, 2015

Presentation

Percutaneous LAA Closure vs Warfarin for A-fib:A Randomized Clinical Trial

Presenter: Vivek Y. Reddy

November 19, 2014

Presentation TCT 2014

TCT 312: Prediction of the True Fractional Flow Reserve of Left Main Coronary Artery Stenosis with Concomitant Downstream Stenoses: In Vitro and In Vivo Experiments

Presenter: Andrejs Erglis, Nicholas J. Lembo, Hadley K. Wilson, Erika Yamamoto

September 16, 2014

Presentation TCT 2014

Prediction of the True Fractional Flow Reserve of Left Main Coronary Artery Stenosis with Concomitant Downstream Stenoses: in vitro and in vivo Experiments_

Presenter: Erika Yamamoto

September 16, 2014

Presentation TCT 2014

Ex-Vivo Simulator for Training, Teaching, and Testing of Transcatheter Valve Therapies Based on the Principle of a Passive Beating Heart

Presenter: Devesh Amatya

September 16, 2014

Presentation TCT 2014

Cost-effectiveness Analysis Of Left Atrial Appendage Occlusion Device Compared With 7 Oral Anticoagulants For Stroke Prevention In Atrial Fibrillation

Presenter: Vivian Lee

September 16, 2014

Presentation TCT 2014

Transcatheter-Based Homologous Off-the-Shelf Tissue Engineered Heart Valves with Self-Repair Capacity: Long-term Functionality and Rapid In Vivo Remodeling in Sheep

Presenter: Susheel Kodali, Nicolo Piazza, Lutz Buellesfeld, Maximilian Y Emmert

September 15, 2014

Presentation TCT 2014

TCT 170: Cost-effectiveness Analysis of a Left Atrial Appendage Occlusion Device Compared with 7 Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation

Presenter: Saibal Kar, Bushra S Rana, Jai-Wun Park, Vivian Lee

September 15, 2014

Advertisement

The Clinical Impact of Stroke With 2 Preventative Strategies: LAA Closure vs Chronic Oral Anticoagulation

KEYNOTE LECTURE: Transcatheter Valve Replacement for Bioprosthetic Valve Failure Gold Standard vs Selective Application (The VIVID Registry)

Are Ablation and LAA Closure Complementary Approaches in the Patient With Paroxysmal AF With Moderate Stroke Risk?

Guidelines, Recommendations, and Reimbursement for LAA Closure: A Global Survey

Guidelines, Recommendations, and Reimbursement for LAA Closure: A Global Survey

Shades of Gray? Defining the Range of Patients Contraindicated for Anticoagulation

Surgical LAA Closure: Patient Selection and Supporting Data

Outcome of Patients With Atrial Fibrillation and Stent Implantation: Results of the Prospective LASER Registry

What Are the Management Options for the Patient With AF and DES?

Which NOAC for Which Patient?

Weighing the Risk of Stroke in Atrial Fibrillation vs the Risk of Bleeding on Anticoagulation

Updates on Mitral Valve-in-Valve/Ring Outcomes From the VIVID Registry

Important Lessons From the Global Valve-in-Valve (VIVID) Registry

Percutaneous LAA Closure vs Warfarin for A-fib:A Randomized Clinical Trial

TCT 312: Prediction of the True Fractional Flow Reserve of Left Main Coronary Artery Stenosis with Concomitant Downstream Stenoses: In Vitro and In Vivo Experiments

Prediction of the True Fractional Flow Reserve of Left Main Coronary Artery Stenosis with Concomitant Downstream Stenoses: in vitro and in vivo Experiments_

Ex-Vivo Simulator for Training, Teaching, and Testing of Transcatheter Valve Therapies Based on the Principle of a Passive Beating Heart

Cost-effectiveness Analysis Of Left Atrial Appendage Occlusion Device Compared With 7 Oral Anticoagulants For Stroke Prevention In Atrial Fibrillation

Transcatheter-Based Homologous Off-the-Shelf Tissue Engineered Heart Valves with Self-Repair Capacity: Long-term Functionality and Rapid In Vivo Remodeling in Sheep

TCT 170: Cost-effectiveness Analysis of a Left Atrial Appendage Occlusion Device Compared with 7 Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content